Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.

Slides:



Advertisements
Similar presentations
Pulmonary Function Testing
Advertisements

The pulse wave.
End of life research in COPD
High-density lipoprotein subclasses in subjects with impaired fasting glucose Filippatos TD 1, Barkas F 1, Klouras E 1, Liontos A 1, Rizos EC 1, Gazi I.
OBESITY AND ASTHMA Dr. Enrico Heffler MD, Specialist in Allergy and Clinical Immunology Allergy and Clinical Immunology - University.
GOLD Clasification Antonio Anzueto MD Professor Medicine University of Texas.
Assessment of Target Organ Damage: Established and Novel Methods Christian Delles BHF Glasgow Cardiovascular Research Centre Institute of Cardiovascular.
Dr. Danny Galdermans Dept Respiratory Medicine ZNA Middelheim Antwerp
Journal Club Alcohol and Health: Current Evidence July–August 2004.
Uncontrolled Hypertension, Systolic and Diastolic Blood Pressure and Development of Symptomatic Peripheral Arterial Disease in the Women’s Health Study.
Overly concerning and falsely reassuring?? FRAMINGHAM RISK FACTORS IN THE ED.
An example of using data from multiple longitudinal studies to address a scientific hypothesis: Maternal iron in pregnancy and offspring’s cardiovascular.
Jennifer Doria-del Castillo
10th Meeting of the Mediterranean Group for the Study of Diabetes Istanbul – April 26-29, 2007 Lung dysfunctions in Metabolic Syndrome and Diabetes Prof.
Introduction Chronic obstructive pulmonary disease (COPD) is related to increased fatigue, decreased health status, and increased mortality. Studies with.
1. Relation between dietary macronutrient and fiber intake with metabolic syndrome in Tehranian adults: Tehran Lipid and Glucose Study Hosseinpour S,
Does Less Lung = More Heart? Nathaniel Marchetti, DO Temple University Philadelphia, PA.
The short-term, between-session reproducibility of Sniff nasal pressure (SnPnas) in COPD patients; Implications for baseline measurements prior to rehabilitation.
ALCOHOL AND HEALTH Morten Grønbæk National Institute of Public Health Copenhagen, Denmark.
Consider testing if person is: – Overweight or obese with additional risk factor for diabetes – Age 45 or older Obtain: A1C or FPG or 2-hour plasma glucose.
Cardiovascular disease in a large cohort of depressed and/or anxious patients Results of the Netherlands Study of Depression and Anxiety N Vogelzangs 1,
Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS.
LUNG FUNCTIONS IN HEALTH AND DISEASE Prof. Sultan Ayoub Meo MBBS, M.Phil, Ph.D (Pak), PG Dip Med Ed (Scotland) FRCP (London), FRCP (Dublin), FRCP (Glasgow),
Mechanistic insights into the relationship between wave reflection and retinal artery flow pulsatility. McDonnell BJ *, Coulson J **, Zagura M***, Munnery.
PWV & PWA Parameter Extraction / Transfer Function.
The association between serum CRP, total cholesterol, triglycerides and coronary artery disease Beata Virginas, Timea Gal.
Arterial stiffness in patients with asthma T.A.Brodskaya Научный руководитель: V.A.Nevzorova, B.I.Geltser Vladivostok State Medical University, Vladivostok,
Effects of endovascular treatment of thoracic aortic diseases on aortic hemodynamics UNIFESP Diego Gaia MD PhD
Use of lung function tests in paediatric asthma care A nationwide registry study Grete Moth, MHSc, Ph.D Danish Paediatric Asthma Centre Aarhus University.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Coupled systolic-ventricular and vascular stiffening.
Loss of anterior forces (R waves) may signify prior anterior myocardial infarction. The aim of the present study was to determine the prevalence and prognostic.
The Use of Statins and Lung Function in Current and Former Smokers. Keddissi JI*, MD, FCCP, Younis WG*, MD, Chbeir EA, MD, Daher NN, MD, Dernaika TA, MD,
E FFECTS OF C ARDIOVASCULAR D RUGS ON M ORTALITY IN S EVERE C HRONIC O BSTRUCTIVE P ULMONARY D ISEASE A T IME -D EPENDENT A NALYSIS Magnus P. Ekstrom,
Impact of Heart Rate on Central Aortic Pressures and Hemodynamics Analysis From the CAFE (Conduit Artery Function Evaluation) Study : CAFE-Heart Rate Bryan.
Date of download: 6/27/2016 Copyright © The American College of Cardiology. All rights reserved. From: Effects of Renal Sympathetic Denervation on Arterial.
Date of download: 7/15/2016 Copyright © The American College of Cardiology. All rights reserved. From: Obstructive sleep apnea and cardiovascular disease.
Date of download: 9/20/2016 Copyright © The American College of Cardiology. All rights reserved. From: Use of radial artery applanation tonometry and a.
Thank you for viewing this presentation.
a cautionary note from SPRINT
Possible malnutrition in the elderly in developed countries
From ESH 2016 | LB 3: Davide Agnoletti, MD
a cautionary note from SPRINT
1 Figure 1: Patient Setup and Sample VENDYS DTM Report
The Minimal Important Difference for St
Non-metabolic syndrome mean (DS) Metabolic syndrome mean (DS)
Why are most clinical research findings not spectacular?
Pulmonary response in sarcoidosis
Pediatric OSA in Obesity:
Blood eosinophil count and exacerbation risk in patients with COPD
Heart Rate, Life Expectancy and the Cardiovascular System: Therapeutic Considerations Cardiology 2015;132: DOI: / Fig. 1. Semilogarithmic.
Improving the Management of COPD in Women
Change in physical activity level following COPD exacerbation
High Blood Pressure (Hypertension)
UOG Journal Club: July 2012 Maternal hemodynamics at 11–13 weeks’ gestation and risk of pre-eclampsia A. Khalil, R. Akolekar, A. Syngelaki, M. Elkhouli.
Chronic Obstructive Pulmonary Disease: An Evidence-Based Approach to Treatment With a Focus on Anticholinergic Bronchodilation  Nicholas J. Gross, MD,
Improving the Management of COPD in Women
Comparison of respiration-induced variations in arterial blood pressure and multi-site photoplethysmographic signals during surgery S Sun1,2, WH Peeters1,
Simplified model of cardiorespiratory control showing coupling between respiratory and cardiovascular systems. τ: circulatory delay; ILV: instantaneous.
Measurement of cardio-ankle vascular index (CAVI).
William T. Abraham et al. JCHF 2015;3:
Association between cardiovascular disease, cardiovascular risk factors and chronic obstructive pulmonary disease (COPD) on mortality. Association between.
Baseline Characteristics of the Subjects*
Pulse wave analyses performed on two 68-yr-old men who were enrolled in the Chronic Renal Insufficiency Cohort Study (60). Pulse wave analyses performed.
Thank you for viewing this presentation.
Mean pulmonary arterial pressure (Ppa) as a function of cardiac output (Q) at two different levels of pulmonary vascular resistance (PVR). Mean pulmonary.
Orly Vardeny et al. JCHF 2016;4:
Distribution of diffusing capacity of the lung for carbon monoxide (DLCO) among 243 scleroderma patients who underwent right heart catheterisation (RHC)
Pulmonary artery pressure in a) healthy subjects and b) pulmonary hypertension (PH) subjects. Pulmonary artery pressure in a) healthy subjects and b) pulmonary.
Increased risk of depression in patients with cutaneous lupus erythematosus and systemic lupus erythematosus: a Danish nationwide cohort study  Jeanette.
Presentation transcript:

Thank you for viewing this presentation. We would like to remind you that this material is the property of the author. It is provided to you by the ERS for your personal use only, as submitted by the author.  2008 by the author

Is COPD a risk factor for increased arterial stiffness? Julie Hjortsø Janner Dept. of Cardiology and Respiratory Medicine Hvidovre University Hospital Copenhagen, Denmark Conflicts of Interest: None

COPD and CVD High risk of CVD is a consequence of COPD? Arterial stiffness predicts CVD Measurements of arterial stiffness: –Pulse wave velocity - PWV –Augmentation index – AIx

Pulse pressure (PP) Augmentation pressure (AP) Systolic pressure Diastolic pressure Pulse wave analysis AIx75 = AP / PP (corrected for heart rate)

COPD and arterial stiffness PWV, AIx and augmentation pressure are increased in patients with COPD R. Sabit et al. Am J Respir Crit Care Med 2007;175: NL. Mills et al. Thorax 2008;63: PWV is increasing with emphysema severity in patients with COPD D. McAllister et al. Am J Respir Crit Care Med 2007;176: Conflicting results regarding PWV association with FEV 1 in the general population M. Zureik et al. Am J Respir Crit Care Med 2001;164: K.Taneda et al. Clin Exp Pharmacol Physiol 2004;31:S31-S34

Hypothesis - Objective Decrease in lung function is associated with increase in AIx75 Examine the association between COPD, lung function (FEV 1, FVC) and arterial stiffness measured by AIx75

Methods Copenhagen City Heart Study – 6300 subjects COPD: –FEV 1 /FVC < 70 % –Age > 40 years –No astma 849 subjects with COPD 550 subjects with COPD (moderate to severe) and measurements of AIx75

AIx75 - COPD COPDNo COPDP-value Men < Women < AIx75 GOLD 1GOLD 2GOLD 3+4P-value Men NS Women NS AIx75

AIx75 – COPD: linear regression model Crude Effect Of COPD

AIx75 – COPD: linear regression model Crude Model 1 Model 2 Crude Model 1 Model 2 Partly adjusted Crude Effect Of COPD Partly adjusted

AIx75 – COPD: linear regression model Crude Effect Of COPD Partly adjusted Fully adjusted

AIx75 – FEV 1 : Generalised additive model Men AIx75 (Diff. from mean) FEV1 (L/min)

AIx75 – FEV 1 : Generalised additive model Men AIx75 (Diff. from mean) FEV1 (L/min) Women

Conclusion COPD is NOT associated with AIx75 after controlling for confounders This could be due to: – No association of arterial stiffness and COPD –AIx75 is an inadequate measurement of arterial stiffness in subjects with COPD

Thank you for your attention The work has been done in cooperation with: –NS. Godtfredsen – Dept. of Respiratory Medicine, Bispebjerg University Hospital, Copenhagen, Denmark –E. Prescott – Dept. of Cardiology, Bispebjerg University Hospital, Copenhagen, Denmark –D. McAllister – ELEGI/Colt Laboratories, MRC Centre for Inflammation Research, University of Edinburgh, Edinburgh, United Kingdom –J. Vestbo – Dept. of Cardiology and Respiratory Medicine, Hvidovre University Hospital, Hvidovre, Denmark Funding: –The Danish Lung Association –The Danish Heart Foundation (08-4-R64-A1992-B ) –The Danish Cardiovascular Research Academy (DaCRA). –ERS (Short-term fellowship)